ABCB1-Mediated Drug Efflux Drives Resistance to VpreB1-Targeted Antibody-Drug Conjugates in B-cell Lymphoblastic Leukemia

An article created on 2026-10-21 03:54:56

#	Наименование новости	Информативность	Дата публикации
1	A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma	13.31	20-10-2026
2	Resistance of breast cancer stem cells to TROP2-targeted CAR-T therapy via the NF-κB signaling pathway	29.05	20-10-2026
3	Cross-Platform Evaluation of a Locked Two-Pathway Transcriptomic Score for Early Mortality in Diffuse Large B-Cell Lymphoma	28.18	19-10-2026
4	Illuminating Innate-Like T-Cell Signaling: From Signaling Architecture to Rational Cancer Immunotherapy	25.47	21-10-2026
5	Integrative transcriptomic and machine learning analyses identify ABCD1 as a diagnostic and prognostic biomarker in cutaneous melanoma	17.47	19-10-2026
6	Intratumoral influenza A virus infection drives platinum resistance and invasive reprogramming in NSCLC	15.26	21-10-2026
7	ASCC1 Promotes Malignant Progression of Pancreatic Cancer by Regulating the NF-κB Signaling Pathway	25.79	20-10-2026
8	Sacubitril/Valsartan for Breast Cancer Therapy-Related Cardiac Dysfunction: An Integrated Meta-Analysis and Bioinformatics Study	23.93	20-10-2026
9	The Effect of Early Neutropenia on PFS with Ribociclib Treatment in Advanced Breast Cancer	13.78	10-08-2026
10	An Interferon-Responsive Cancer-Associated Fibroblast Subtype Shapes an Immune-Active Tumor Microenvironment and Favors Survival in Ovarian Cancer	24.79	20-10-2026

Классификация: Информация. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 36.32. Источник: www.researchsquare.com.

Найдите то, что Вас интересует